The vector delivery platform’s potential application beyond wet AMD, as seen with trials in diabetic macular edema and other conditions, expands the breadth of opportunities for 4D Molecular ...

Tired of paying for Adobe Illustrator's monthly subscription fees? Here are eight alternatives for anyone who needs vector ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one pediatric patient as of data ...

In October 2023, Sarepta said the confirmatory EMBARK trial did not meet its primary ... delandistrogene moxeparvovec (1.33 × 10 14 vector genomes per kg) or placebo. Mean age was about 6 ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

Young Thug’s lengthy and embattled trial on racketeering conspiracy charges took another dramatic turn Thursday when defense teams took turns meeting privately with prosecutors to discuss ...

Malware disguised as a Python-based trading bot has reportedly targeted crypto traders in a multi-vector supply chain attack.

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...